Panel recommends new, better shingles shot over old version


Make text smaller Make text larger



Photos





By MIKE STOBBE

A federal panel is recommending that older people vaccinated for shingles get a new, better shot approved in October.

The advisory panel said the vaccine made by GlaxoSmithKline works better than the first one made by Merck, which has been sold in the U.S. since 2006. Health officials say many as 20 million Americans should get a second round.

Shingles, a painful blistery condition, occurs when the chickenpox virus resurfaces later in life. Merck's vaccine is recommended for people 60 and older. But health officials say its effectiveness drops sharply after about five years.

The Advisory Committee on Immunization Practices said doctors should first opt for Glaxo's Shingrix, licensed last week, which uses a new ingredient to boost its effectiveness. It was recommended for people 50 and older.



Make text smaller Make text larger

Comments

Pool Rules



MUST READ NEWS

Goshen farmers market is a feast for the senses
By Geri Corey
GOSHEN — Once more the village of Goshen was bustling with activity as the grand opening of the 2018 farmers market took place on Friday, June 1.
The...

Read more »
Image

Cancer center honors 'Great Guy' Kevin Hayes
— Kevin Hayes of Mobile Life Support Services was among four "Great Guys" honored by the Hudson Valley Cancer...
Read more »
Image

Where in Chester?
Where in Chester have you seen this detail? If you think you know, fill out the form below.
Read more »
Image

Where in Chester?
Liam and Mollie Hawthorne of Monroe knew exactly where to find the detail in last week's clue.
"The Hall of Fame of the Trotter," they...

Read more »
Image

VIDEOS



Subscribe to our mailing list

* indicates required
Community Newspapers


MOST COMMENTED



Find more about Weather in Chester, NY